Anti-BACE1 antibody [EPR19523] (Ab183612)
BACE, KIAA1149, BACE1, Beta-secretase 1, Aspartyl protease 2, Beta-site amyloid precursor protein cleaving enzyme 1, Memapsin-2, Membrane-associated aspartic protease 2, ASP2, Asp 2, Beta-site APP cleaving enzyme 1
详细信息
特异性
This antibody shows very low cross-reactivity with BACE2.
背景信息
What is this antibody validated in? Anti-BACE1 antibody [EPR19523] (ab183612) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr) in Human, Mouse, Rat samples. What is the molecular weight of BACE1? Anti-BACE1 [EPR19523] (ab183612) specifically detects a band for BACE1 (UniProt: P56818) at a molecular weight of 56kDa. Trusted by the scientific community Anti-BACE1 [EPR19523] (ab183612) was first used in a scientific publication in 2016 and has been cited over 30 times in peer-reviewed journals. Reviewed by scientists Anti-BACE1 [EPR19523] (ab183612) has over 5 independent reviews from customers. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies. Specificity confirmed The specificity of Anti-BACE1 antibody [EPR19523] (ab183612) has been confirmed by Western blot testing in BACE1 Knockout HAP1 cells. Other related products We have a range of other formats of antibody clone [EPR19523] also available for your convenience: ab183612, Carrier free - ab238937, Alexa Fluor® 647 - ab225307 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (64)
Synaptic Vesicle Glycoprotein 2A Suppresses Amyloidogenesis Beyond Its Synaptic Role: A Novel Mechanism Disrupting BACE1 Binding and Altering APP Localization.
突触囊泡糖蛋白 2A 抑制淀粉样蛋白形成,超越其突触作用:一种破坏 BACE1 结合和改变 APP 定位的新机制。
Long noncoding RNA GAS5 acts as a competitive endogenous RNA to regulate GSK-3β and PTEN expression by sponging miR-23b-3p in Alzheimer's disease.
长链非编码 RNA GAS5 作为一种竞争性内源 RNA,通过吸附 miR-23b-3p 来调节阿尔茨海默病中的 GSK-3β 和 PTEN 表达
Putative long range mossy fiber sprouting and regional cytochrome c oxidase alteration in the hippocampus of patients with mesial temporal lobe epilepsy.
内侧颞叶癫痫患者海马中假定的长程苔藓纤维萌发和区域细胞色素c氧化酶改变。
Nobiletin Ameliorates Alzheimer's Disease Pathology by Reducing Oxidative Stress and Neuroinflammation Through the AMPK/SIRT1/PGC-1α and PI3K/Akt-CREB-BDNF Pathways in 5XFAD Mice.
诺比列汀通过 AMPK/SIRT1/PGC-1α 和 PI3K/Akt-CREB-BDNF 通路减少氧化应激和神经炎症,从而改善 5XFAD 小鼠的阿尔茨海默病病理。
Targeted delivery of BACE1 siRNA for synergistic treatment of Alzheimer's disease.
靶向递送 BACE1 siRNA 用于阿尔茨海默病的协同治疗
Pharmacologic inhibition of PCBP2 biomolecular condensates relieves Alzheimer's disease
药理学抑制PCBP2生物分子凝聚体可缓解阿尔茨海默病
Berberine-inspired ionizable lipid for self-structure stabilization and brain targeting delivery of nucleic acid therapeutics
受小檗碱启发的可电离脂质用于自身结构稳定和核酸疗法的脑靶向递送
Gut microbial-derived indole-3-propionate improves cognitive function in Alzheimer's disease.
肠道微生物来源的吲哚-3-丙酸酯可改善阿尔茨海默病患者的认知功能。
Multifunctional natural chlorogenic acid based nanocarrier for Alzheimer's disease treatment.
用于治疗阿尔茨海默病的多功能天然绿原酸基纳米载体
Microglial double stranded DNA accumulation induced by DNase II deficiency drives neuroinflammation and neurodegeneration
DNase II 缺乏诱导的小胶质细胞双链 DNA 积累会驱动神经炎症和神经退行性变。
- 1
- 2
- 3
- 4
- 5
- 6
- 7